Author Teunissen, Charlotte E.

1 to 10 of 17 Items
  • 2012 Review
    ​ ​Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update​
    del Campo, M.; Mollenhauer, B.; Bertolotto, A.; Engelborghs, S.; Hampel, H.; Simonsen, A. H.& Kapaki, E. et al.​ (2012)
    Biomarkers in Medicine, 6​(4) pp. 419​-430​.​
    Future Medicine Ltd. DOI: https://doi.org/10.2217/BMM.12.46 
    Details  DOI  PMID  PMC  WoS 
  • 2014 Journal Article
    ​ ​The influence of genetic variants in SORL1 gene on the manifestation of Alzheimer's disease​
    Louwersheimer, E.; Ramirez, A.; Cruchaga, C.; Becker, T.; Kornhuber, J. ; Peters, O. & Heilmann, S. et al.​ (2014) 
    Neurobiology of Aging36(3) pp. 1605.e13​-1605.e20​.​ DOI: https://doi.org/10.1016/j.neurobiolaging.2014.12.007 
    Details  DOI 
  • 2014 Journal Article
    ​ ​SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease​
    Ramirez, A.; van der Flier, W. M.; Herold, C.; Ramonet, D.; Heilmann, S.; Lewczuk, P.   & Popp, J. et al.​ (2014) 
    Human Molecular Genetics23(24) pp. 6644​-6658​.​ DOI: https://doi.org/10.1093/hmg/ddu372 
    Details  DOI 
  • 2014 Journal Article
    ​ ​Biobanking of CSF: International standardization to optimize biomarker development​
    Teunissen, C. E.; Tumani, H.; Engelborghs, S. & Mollenhauer, B.​ (2014) 
    Clinical Biochemistry47(4-5) pp. 288​-292​.​ DOI: https://doi.org/10.1016/j.clinbiochem.2013.12.024 
    Details  DOI  PMID  PMC  WoS 
  • 2015 Journal Article | 
    ​ ​The central biobank and virtual biobank of BiOMarKaPD: a resource for studies on neurodegenerative diseases​
    Reijs, B. L. R.; Teunissen, C. E.; Goncharenko, N.; Betsou, F.; Blennow, K.; Baldeiras, I. & Brosseron, F. et al.​ (2015) 
    Frontiers in Neurology6 art. UNSP 216​.​ DOI: https://doi.org/10.3389/fneur.2015.00216 
    Details  DOI  PMID  PMC  WoS 
  • 2015 Journal Article | 
    ​ ​A practical guide to immunoassay method validation​
    Andreasson, U.; Perret-Liaudet, A.; van Waalwijk van Doorn, L. J. C.; Blennow, K.; Chiasserini, D.; Engelborghs, S. & Fladby, T. et al.​ (2015) 
    Frontiers in Neurology6 art. UNSP 179​.​ DOI: https://doi.org/10.3389/fneur.2015.00179 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Journal Article
    ​ ​Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics​
    Lelental, N.; Brandner, S.; Kofanova, O.; Blennow, K.; Zetterberg, H.; Andreasson, U. & Engelborghs, S. et al.​ (2016) 
    Journal of Alzheimer's Disease52(1) pp. 51​-64​.​ DOI: https://doi.org/10.3233/jad-150883 
    Details  DOI 
  • 2016 Journal Article
    ​ ​Validation of soluble amyloid-β precursor protein assays as diagnostic CSF biomarkers for neurodegenerative diseases​
    van Waalwijk van Doorn, L. J. C.; Koel-Simmelink, M. J.; Haußmann, U.; Klafki, H. ; Struyfs, H.; Linning, P. & Knölker, H.-J. et al.​ (2016) 
    Journal of Neurochemistry137(1) pp. 112​-121​.​ DOI: https://doi.org/10.1111/jnc.13527 
    Details  DOI  PMID  PMC 
  • 2016 Journal Article
    ​ ​Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort​
    Steenoven, I. van; Aarsland, D.; Weintraub, D.; Londos, E.; Blanc, F.; van der Flier, W. M. & Teunissen, C. E. et al.​ (2016) 
    Journal of Alzheimer s Disease54(1) pp. 287​-295​.​ DOI: https://doi.org/10.3233/JAD-160322 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Journal Article
    ​ ​Multicenter immunoassay validation of cerebrospinal fluid neurofilament light: a biomarker for neurodegeneration​
    Miller, A.-M.; Rutkowska, A.; Bahl, J. M. C.; Herukka, S.-K.; Koel-Simmelink, M. J. A.; Kruse, N. & Mollenhauer, B. et al.​ (2016) 
    Bioanalysis8(21) pp. 2243​-2254​.​ DOI: https://doi.org/10.4155/bio-2016-0114 
    Details  DOI  PMID  PMC  WoS 

Researcher

Sort

issue date

ASC DESC

Items per Page